Table of Contents

- D A Gough and
- J C Armour
Development of the implantable glucose sensor. What are the prospects and why is it taking so long?
Diabetes September 1995 44:1005-1009
Select this article
- F Dela,
- J J Larsen,
- K J Mikines,
- T Ploug,
- L N Petersen,
- and H Galbo
Insulin-stimulated muscle glucose clearance in patients with NIDDM. Effects of one-legged physical training.
Diabetes September 1995 44:1010-1020; doi:10.2337/diabetes.44.9.1010
- Abstract
Select this article
- R Veijola,
- P Vähäsalo,
- E Tuomilehto-Wolf,
- H Reijonen,
- P Kulmala,
- J Ilonen,
- H K Akerblom,
- and M Knip
Human leukocyte antigen identity and DQ risk alleles in autoantibody-positive siblings of children with IDDM are associated with reduced early insulin response. Childhood Diabetes in Finland (DiMe) Study Group.
Diabetes September 1995 44:1021-1028; doi:10.2337/diabetes.44.9.1021
- Abstract
Select this article
- C Lévy-Marchal,
- F Dubois,
- M Noël,
- J Tichet,
- and P Czernichow
Immunogenetic determinants and prediction of IDDM in French schoolchildren.
Diabetes September 1995 44:1029-1032; doi:10.2337/diabetes.44.9.1029
- Abstract
Select this article
- W Krugluger,
- H P Kopp,
- G Schernthaner,
- and P Hopmeier
Enhanced anticoagulant response to activated protein C in patients with IDDM.
Diabetes September 1995 44:1033-1037; doi:10.2337/diabetes.44.9.1033
- Abstract
Select this article
- K Rebrin,
- G M Steil,
- L Getty,
- and R N Bergman
Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin.
Diabetes September 1995 44:1038-1045; doi:10.2337/diabetes.44.9.1038
- Abstract
Select this article
- B D Mitchell,
- C M Kammerer,
- P O'Connell,
- C R Harrison,
- M Manire,
- P Shipman,
- M P Moyer,
- M P Stern,
- and M L Frazier
Evidence for linkage of postchallenge insulin levels with intestinal fatty acid-binding protein (FABP2) in Mexican-Americans.
Diabetes September 1995 44:1046-1053; doi:10.2337/diabetes.44.9.1046
- Abstract
Select this article
- J Nourooz-Zadeh,
- J Tajaddini-Sarmadi,
- S McCarthy,
- D J Betteridge,
- and S P Wolff
Elevated levels of authentic plasma hydroperoxides in NIDDM.
Diabetes September 1995 44:1054-1058; doi:10.2337/diabetes.44.9.1054
- Abstract
Select this article
- M H Cummings,
- G F Watts,
- A M Umpleby,
- T R Hennessy,
- J M Kelly,
- N C Jackson,
- and P H Sönksen
Acute hyperinsulinemia decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM.
Diabetes September 1995 44:1059-1065; doi:10.2337/diabetes.44.9.1059
- Abstract
Select this article
- C A Raguso,
- A R Coggan,
- A Gastaldelli,
- L S Sidossis,
- E J Bastyr, 3rd,
- and R R Wolfe
Lipid and carbohydrate metabolism in IDDM during moderate and intense exercise.
Diabetes September 1995 44:1066-1074; doi:10.2337/diabetes.44.9.1066
- Abstract
Select this article
- F Vollenweider,
- J Kaufmann,
- J C Irminger,
- and P A Halban
Processing of proinsulin by furin, PC2, and PC3 in (co) transfected COS (monkey kidney) cells.
Diabetes September 1995 44:1075-1080; doi:10.2337/diabetes.44.9.1075
- Abstract
Select this article
- M Kan,
- F Kanai,
- M Iida,
- H Jinnouchi,
- M Todaka,
- T Imanaka,
- K Ito,
- Y Nishioka,
- T Ohnishi,
- and S Kamohara
Frequency of mutations of insulin receptor gene in Japanese patients with NIDDM.
Diabetes September 1995 44:1081-1086; doi:10.2337/diabetes.44.9.1081
- Abstract
Select this article
- P W Young,
- M A Cawthorne,
- P J Coyle,
- J C Holder,
- G D Holman,
- I J Kozka,
- D M Kirkham,
- C A Lister,
- and S A Smith
Repeat treatment of obese mice with BRL 49653, a new potent insulin sensitizer, enhances insulin action in white adipocytes. Association with increased insulin binding and cell-surface GLUT4 as measured by photoaffinity labeling.
Diabetes September 1995 44:1087-1092; doi:10.2337/diabetes.44.9.1087
- Abstract
Select this article
- R L Klein,
- M Laimins,
- and M F Lopes-Virella
Isolation, characterization, and metabolism of the glycated and nonglycated subfractions of low-density lipoproteins isolated from type I diabetic patients and nondiabetic subjects.
Diabetes September 1995 44:1093-1098; doi:10.2337/diabetes.44.9.1093
- Abstract
Select this article
- M Orho,
- P Nikula-Ijäs,
- C Schalin-Jäntti,
- M A Permutt,
- and L C Groop
Isolation and characterization of the human muscle glycogen synthase gene.
Diabetes September 1995 44:1099-1105; doi:10.2337/diabetes.44.9.1099
- Abstract
Select this article
- G M Pieper,
- M Jordan,
- M B Adams,
- and A M Roza
Syngeneic pancreatic islet transplantation reverses endothelial dysfunction in experimental diabetes.
Diabetes September 1995 44:1106-1113; doi:10.2337/diabetes.44.9.1106
- Abstract
Select this article
- R Huang,
- J Guo,
- X Li,
- and D L Faustman
Elimination of self-peptide major histocompatibility complex class I reactivity in NOD and beta 2-microglobulin-negative mice.
Diabetes September 1995 44:1114-1120; doi:10.2337/diabetes.44.9.1114
- Abstract
Select this article
- B Ludvik,
- J J Nolan,
- J Baloga,
- D Sacks,
- and J Olefsky
Effect of obesity on insulin resistance in normal subjects and patients with NIDDM.
Diabetes September 1995 44:1121-1125; doi:10.2337/diabetes.44.9.1121
- Abstract
Select this article
- C F Deacon,
- M A Nauck,
- M Toft-Nielsen,
- L Pridal,
- B Willms,
- and J J Holst
Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects.
Diabetes September 1995 44:1126-1131; doi:10.2337/diabetes.44.9.1126
- Abstract
Select this article
- D Elias and
- I R Cohen
Treatment of autoimmune diabetes and insulitis in NOD mice with heat shock protein 60 peptide p277.
Diabetes September 1995 44:1132-1138; doi:10.2337/diabetes.44.9.1132
- Abstract

Diabetes

Development of the implantable glucose sensor. What are the prospects and why is it taking so long?

Insulin-stimulated muscle glucose clearance in patients with NIDDM. Effects of one-legged physical training.

Human leukocyte antigen identity and DQ risk alleles in autoantibody-positive siblings of children with IDDM are associated with reduced early insulin response. Childhood Diabetes in Finland (DiMe) Study Group.

Immunogenetic determinants and prediction of IDDM in French schoolchildren.

Enhanced anticoagulant response to activated protein C in patients with IDDM.

Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin.

Evidence for linkage of postchallenge insulin levels with intestinal fatty acid-binding protein (FABP2) in Mexican-Americans.

Elevated levels of authentic plasma hydroperoxides in NIDDM.

Acute hyperinsulinemia decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM.

Lipid and carbohydrate metabolism in IDDM during moderate and intense exercise.

Processing of proinsulin by furin, PC2, and PC3 in (co) transfected COS (monkey kidney) cells.

Frequency of mutations of insulin receptor gene in Japanese patients with NIDDM.

Repeat treatment of obese mice with BRL 49653, a new potent insulin sensitizer, enhances insulin action in white adipocytes. Association with increased insulin binding and cell-surface GLUT4 as measured by photoaffinity labeling.

Isolation, characterization, and metabolism of the glycated and nonglycated subfractions of low-density lipoproteins isolated from type I diabetic patients and nondiabetic subjects.

Isolation and characterization of the human muscle glycogen synthase gene.

Syngeneic pancreatic islet transplantation reverses endothelial dysfunction in experimental diabetes.

Elimination of self-peptide major histocompatibility complex class I reactivity in NOD and beta 2-microglobulin-negative mice.

Effect of obesity on insulin resistance in normal subjects and patients with NIDDM.

Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects.

Treatment of autoimmune diabetes and insulitis in NOD mice with heat shock protein 60 peptide p277.

This Issue

Current Issue